Sigma® Life Science and King’s College London co-developing miRNA Target Identification Technology
5 May 2011 | By kdm communications limited
Exclusive license to develop and commercialize new technology...
List view / Grid view
News
Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
5 May 2011 | By The Scott Partnership
Novozymes Biopharma, unveiled its enhanced next-generation albumin technology...
The European Commission approves Pfizer’s Revatio® (sildenafil)
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
Small, smaller, Ministat!
5 May 2011 | By Peter Huber Kältemaschinenbau GmbH
Huber Ministats are the smallest cooling thermostats in the world! Despite their size Ministats have enough power...
Sanofi-aventis and Medicines for Malaria Venture join forces to develop innovative malaria drugs
5 May 2011 | By Sanofi-Aventis
Sanofi-aventis and MMV announced that they have signed an alliance agreement...
Gilead extends its funding support for the Gilead Sciences Research Centre
5 May 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. has extended its funding support of the Gilead Sciences Research Centre at the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague...
ERT Announces Appointment of New President and CEO
4 May 2011 | By The Scott Partnership
ERT, has appointed Jeffrey S. Litwin, as its new President and Chief Executive Officer and as a member of the board...
Thermo Fisher Scientific announces upgrade program for NanoDrop Instruments
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new upgrade program that includes the donation of reconditioned Thermo Scientific NanoDrop 1000 spectrophotometers to academic institutions in developing countries.
FDA approves linagliptin tablets for the treatment of type 2 diabetes
3 May 2011 | By OgilvyHealthPR
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy…
Teva to acquire Cephalon in $6.8 billion transaction
2 May 2011 | By Cephalon, Inc.
Teva will acquire all of the outstanding shares of Cephalon for a total enterprise value of approximately $6.8 billion...
GE Healthcare to acquire cellular imaging company Applied Precision, Inc.
28 April 2011 | By College Hill Ltd
GE Healthcare, today announced it has reached an agreement to acquire Applied Precision, Inc...
Thermo Fisher Scientific to highlight new laboratory solutions during UK summer symposium
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a free summer symposium presenting the latest developments in laboratory solutions.
Johnson & Johnson to buy orthopedic device maker Synthes for $21.3 billion
28 April 2011 | By Johnson & Johnson
Johnson & Johnson and Synthes announce definitive merger agreement to create world’s most comprehensive orthopaedics business...
AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent
28 April 2011 | By POZEN Inc.
AstraZeneca and POZEN have filed a patent infringement lawsuit against Dr. Reddy's relating to VIMOVO(TM)...
Lilly and Medtronic announce drug-device collaboration for Parkinson’s Disease
27 April 2011 | By Eli Lilly & Company
Collaboration combines companies' expertise in neuroscience and targeted drug delivery...
